New

Europe Molecular Biology Enzymes, Kits, and Reagents Market

2021

Europe Molecular Biology Enzymes, Kits, and Reagents Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Enzymes and Kits & Reagents), Application (Epigenetics, Sequencing, Synthetic Biology, Polymerase Chain Reaction, and Other), and End User (Biotechnological & Pharmaceutical Companies, Hospitals & Diagnostic Centers, and Academic & Research Institutes)

Publication Month: Nov 2021 | Report Code: TIPRE00025774 | No. of Pages: 184 | Category: Biotechnology | Status: Published

Market Insights

Europe Molecular Biology Enzymes, Kits, and Reagents Market to Grow at a CAGR of 17.2% to reach US$ 12,561.60 million Million from 2021 to 2028

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!

The molecular biology enzymes, kits, and reagents market in Europe is expected to grow from US$ 4,125.28 million in 2021 to US$ 12,561.60 million by 2028; it is estimated to grow at a CAGR of 17.2% from 2021 to 2028.

France, Germany, Italy, Spain, and UK are major economies in Europe. Sequencing procedures becoming cheaper is the major factor driving the growth of the Europe molecular biology enzymes, kits, and reagents market. The cost of genome sequencing, as well as next-generation sequencing, has dropped radically in the past 6–7 years. For instance, the whole human genome sequencing cost was ~US$ 3.7 billion in 2000, and the process took more than a decade for the completion. However, the costs of this process dropped down to US$ 10 million in 2006 and US$ 5,000 in 2012; it has further reduced to US$ 1,000 in recent years. Moreover, the process requires a lesser number of days for completion. In 2003, the International Human Genome Sequencing Consortium started the genome analysis by sequencing a complete human genome. The sequencing cost was ~US$ 2.6 billion (EUR 2.3 billion). By 2008, costs dropped to lower than US$ 1.4 million (EUR 1 billion) per genome. However, now, it costs US$ 400–500 to sequence an exome and US$ 1,000–1,200 to sequence a genome. The decline in the cost can be checked by the cost to sequence a genome diverging drastically around 2008, falling from approximately US$ 10 million to nearly US$ 1,000 at the present date. Lowering costs and accelerating the overall process would enable service providers to secure larger profit margins, along with helping them expand their clientele. The latest machines offered by Illumina are a lower priced and are available in two models—NovaSeq 5000 priced at US$ 850,000 and NovaSeq 6000 priced at US$ 985,000. DNA sequencing company, Illumina introduced its first machine for the human genome sequencing for US$ 300,000 in 2006, and in 2014, it unveiled the machine at a cost reduced to US$ 1,000. Thus, the lowered cost of genome sequencing is propelling the number of molecular biology procedures carried out for different purpose, thereby driving the use of enzymes, kits, and reagents.

Italy, Spain, the UK, Germany, France, and several other European counties such as Russia and Switzerland were highly affected. The European economy is severely affected due to the exponential growth of COVID-19 cases in the region. Spain, Italy, Germany, France, and the UK were among the most affected European countries, and the number of deaths was also high. The COVID-19 outbreak has been declared by the World Health Organization (WHO) as a Public Health Emergency of International Concern, according to the International Health Regulations. Increasing number of product launches in 2020 and the rising incidence of COVID-19 have positively impacted the Europe molecular biology enzymes, kits & reagents market. In 2020, European Medicines Agency (EMA) approved about 97 medicines for marketing authorization, of which 39 are novel drugs. Similarly, in October 2020, Eurofins introduced COVID-19 PCR tests with at-home self-sampling options in Europe.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Europe molecular biology enzymes, kits, and reagents market. The Europe molecular biology enzymes, kits, and reagents market is expected to grow at a good CAGR during the forecast period.

Europe Molecular Biology Enzymes, Kits, and Reagents Market Segmentation

Europe Molecular Biology Enzymes, Kits, and Reagents Market – By Product

  • Enzymes
    • Polymerases
    • Ligases
    • Reverse Transcriptases
    • Phosphatases
    • Proteases and Proteinases
    • Restriction Endonuclease
    • Other
  • Kits and Reagents

Europe Molecular Biology Enzymes, Kits, and Reagents Market – By Application

  • Epigenetics
  • Sequencing
  • Synthetic Biology
  • Polymerase Chain Reaction
  • Other

Europe Molecular Biology Enzymes, Kits, and Reagents Market – By End User

  • Biotechnological and Pharmaceutical Companies
  • Hospitals and Diagnostic Centres
  • Academic and Research Institutes

Europe Molecular Biology Enzymes, Kits, and Reagents Market, by Country

  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe

Europe Molecular Biology Enzymes, Kits, and Reagents Market - Companies Mentioned

  • Agilent Technologies, Inc.
  • F. HOFFMANN-LA ROCHE LTD
  • Illumina, Inc.
  • Merck KGAA
  • MERIDIAN BIOSCIENCE, INC
  • Promega Corporation
  • Qiagen
  • Rockland Immunochemicals Inc
  • THERMO FISHER SCIENTIFIC INC

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Europe Molecular Biology Enzymes, Kits & Reagents Market – By Product

1.3.2 Europe Molecular Biology Enzymes, Kits & Reagents Market – By Application

1.3.3 Europe Molecular Biology Enzymes, Kits & Reagents Market – By End-User

1.3.4 Europe Molecular Biology Enzymes, Kits & Reagents Market – By Country

2. Europe Molecular Biology Enzymes, Kits & Reagents Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Europe Molecular Biology Enzymes, Kits & Reagents Market – Market Landscape

4.1 Europe PEST Analysis

4.1.1 Expert Opinion

5. Europe Molecular Biology Enzymes, Kits & Reagents Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Genomics Getting Financial Assistance

5.1.2 Sequencing Procedures Becoming Cheaper

5.1.3 Chronic Diseases Becoming More Prevalent

5.2 Market Restraints

5.2.1 Lack of Skilled Professionals

5.3 Market Opportunities

5.3.1 Surge in Acceptance of Molecular Diagnostics

5.4 Future Trends

5.4.1 Personalized Medicines at Huge Demand

5.5 Impact analysis

6. Molecular Biology Enzymes, Kits & Reagents Market – Europe Analysis

6.1 Europe Molecular Biology Enzymes, Kits & Reagents Market Revenue Forecast and Analysis

7. Europe Molecular Biology Enzymes, Kits & Reagents Market Analysis – By Product

7.1 Overview

7.2 Europe Molecular Biology Enzymes, Kits & Reagents Market Revenue Share, by Product (2020 and 2028)

7.3 Enzymes

7.3.1 Overview

7.3.2 Enzymes: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)

7.3.3 Polymerases

7.3.3.1 Overview

7.3.3.2 Polymerases: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)

7.3.4 Ligase

7.3.4.1 Overview

7.3.4.2 Ligase: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)

7.3.5 Reverse Transcriptases

7.3.5.1 Overview

7.3.5.2 Reverse Transcriptases: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)

7.3.6 Phosphatases

7.3.6.1 Overview

7.3.6.2 Phosphatases: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)

7.3.7 Proteases and Proteinases

7.3.7.1 Overview

7.3.7.2 Proteases and Proteinases: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)

7.3.8 Restriction Endonuclease

7.3.8.1 Overview

7.3.8.2 Restriction Endonuclease: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)

7.3.9 Other

7.3.9.1 Overview

7.3.9.2 Other: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)

7.4 Kits and Reagents

7.4.1 Overview

7.4.2 Kits and Reagents: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)

8. Europe Molecular Biology Enzymes, Kits & Reagents Market Analysis – By Application

8.1 Overview

8.2 Europe Molecular Biology Enzymes, Kits & Reagents Market Revenue Share, by Application (2020 and 2028)

8.3 Polymerase Chain Reaction

8.3.1 Overview

8.3.2 Polymerase Chain Reaction: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)

8.4 Sequencing

8.4.1 Overview

8.4.2 Sequencing: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)

8.5 Synthetic Biology

8.5.1 Overview

8.5.2 Synthetic Biology: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)

8.6 Epigenetics

8.6.1 Overview

8.6.2 Epigenetics: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)

8.7 Others

8.7.1 Overview

8.7.2 Others: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)

9. Europe Molecular Biology Enzymes, Kits & Reagents Market – By End User

9.1 Overview

9.2 Europe Molecular Biology Enzymes, Kits & Reagents Market, by End User, 2020 and 2028 (%)

9.3 Biotechnological and Pharmaceutical Companies

9.3.1 Overview

9.3.2 Biotechnological and Pharmaceutical Companies: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)

9.4 Hospitals and Diagnostic Centers

9.4.1 Overview

9.4.2 Hospitals and Diagnostic Centers: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)

9.5 Academic and Research Institutes

9.5.1 Overview

9.5.2 Academic and Research Institutes: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)

10. Europe Molecular Biology Enzymes, Kits & Reagents Market – Country Analysis

10.1 Overview

10.1.1 Europe: Molecular Biology Enzymes, Kits & Reagents Market, by Country, 2020 & 2028 (%)

10.1.1.1 Germany

10.1.1.1.1 Germany: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.1.2 Germany: Molecular Biology Enzymes, Kits & Reagents Market, by Product, 2019–2028 (USD Million)

10.1.1.1.3 Germany: Molecular Biology Enzymes, Kits & Reagents Market, by Enzymes, 2019–2028 (USD Million)

10.1.1.1.4 Germany: Molecular Biology Enzymes, Kits & Reagents Market, by Application, 2019–2028 (USD Million)

10.1.1.1.5 Germany: Molecular Biology Enzymes, Kits & Reagents Market, by End User, 2019–2028 (USD Million)

10.1.1.2 France

10.1.1.2.1 France: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.2.2 France: Molecular Biology Enzymes, Kits & Reagents Market, by Product, 2019–2028 (USD Million)

10.1.1.2.3 France: Molecular Biology Enzymes, Kits & Reagents Market, by Enzymes, 2019–2028 (USD Million)

10.1.1.2.4 France: Molecular Biology Enzymes, Kits & Reagents Market, by Application, 2019–2028 (USD Million)

10.1.1.2.5 France: Molecular Biology Enzymes, Kits & Reagents Market, by End User, 2019–2028 (USD Million)

10.1.1.3 United Kingdom

10.1.1.3.1 United Kingdom: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.3.2 United Kingdom: Molecular Biology Enzymes, Kits & Reagents Market, by Product, 2019–2028 (USD Million)

10.1.1.3.3 United Kingdom: Molecular Biology Enzymes, Kits & Reagents Market, by Enzymes, 2019–2028 (USD Million)

10.1.1.3.4 United Kingdom: Molecular Biology Enzymes, Kits & Reagents Market, by Application, 2019–2028 (USD Million)

10.1.1.3.5 United Kingdom: Molecular Biology Enzymes, Kits & Reagents Market, by End User, 2019–2028 (USD Million)

10.1.1.4 Italy

10.1.1.4.1 Italy: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.4.2 Italy: Molecular Biology Enzymes, Kits & Reagents Market, by Product, 2019–2028 (USD Million)

10.1.1.4.3 Italy: Molecular Biology Enzymes, Kits & Reagents Market, by Enzymes, 2019–2028 (USD Million)

10.1.1.4.4 Italy: Molecular Biology Enzymes, Kits & Reagents Market, by Application, 2019–2028 (USD Million)

10.1.1.4.5 Italy: Molecular Biology Enzymes, Kits & Reagents Market, by End User, 2019–2028 (USD Million)

10.1.1.5 Spain

10.1.1.5.1 Spain: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.5.2 Spain: Molecular Biology Enzymes, Kits & Reagents Market, by Product, 2019–2028 (USD Million)

10.1.1.5.3 Spain: Molecular Biology Enzymes, Kits & Reagents Market, by Enzymes, 2019–2028 (USD Million)

10.1.1.5.4 Spain: Molecular Biology Enzymes, Kits & Reagents Market, by Application, 2019–2028 (USD Million)

10.1.1.5.5 Spain: Molecular Biology Enzymes, Kits & Reagents Market, by End User, 2019–2028 (USD Million)

10.1.1.6 Rest of Europe

10.1.1.6.1 Rest of Europe: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.6.2 Rest of Europe: Molecular Biology Enzymes, Kits & Reagents Market, by Product, 2019–2028 (USD Million)

10.1.1.6.3 Rest of Europe: Molecular Biology Enzymes, Kits & Reagents Market, by Enzymes, 2019–2028 (USD Million)

10.1.1.6.4 Rest of Europe: Molecular Biology Enzymes, Kits & Reagents Market, by Application, 2019–2028 (USD Million)

10.1.1.6.5 Rest of Europe: Molecular Biology Enzymes, Kits & Reagents Market, by End User, 2019–2028 (USD Million)

11. Impact of COVID-19 Pandemic on Europe Molecular Biology Enzymes, Kits & Reagents Market

11.1 Europe: Impact Assessment of COVID-19 Pandemic

12. Molecular Biology Enzymes, Kits & Reagents Market Industry Landscape

12.1 Overview

12.2 Growth Strategies In The Molecular Biology Enzymes, Kits & Reagents Devices Market, 2018-2021

12.3 Organic Growth Strategies

12.3.1 Overview

12.3.2 Recent Organic Developments in the Molecular Biology Enzymes, Kits & Reagents Market

12.4 Inorganic Growth Strategies

12.4.1 Overview

13. Company Profiles

13.1 HOFFMANN-LA ROCHE LTD.

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 MERCK KGaA

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 Illumina, Inc.

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 QIAGEN

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 Agilent Technologies, Inc.

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 Jena Bioscience GmbH

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 THERMO FISHER SCIENTIFIC INC.

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 MERIDIAN BIOSCIENCE, INC.

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

13.9 Promega Corporation

13.9.1 Key Facts

13.9.2 Business Description

13.9.3 Products and Services

13.9.4 Financial Overview

13.9.5 SWOT Analysis

13.9.6 Key Developments

14. Appendix

14.1 About The Insight Partners

14.2 Glossary of Terms

LIST OF TABLES

Table 1. Germany: Molecular Biology Enzymes, Kits & Reagents Market, by Product– Revenue and Forecast to 2028 (USD Million)

Table 2. Germany: Molecular Biology Enzymes, Kits & Reagents Market, by Enzymes– Revenue and Forecast to 2028 (USD Million)

Table 3. Germany: Molecular Biology Enzymes, Kits & Reagents Market, by Application– Revenue and Forecast to 2028 (USD Million)

Table 4. Germany: Molecular Biology Enzymes, Kits & Reagents Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 5. France: Molecular Biology Enzymes, Kits & Reagents Market, by Product– Revenue and Forecast to 2028 (USD Million)

Table 6. France: Molecular Biology Enzymes, Kits & Reagents Market, by Enzymes– Revenue and Forecast to 2028 (USD Million)

Table 7. France: Molecular Biology Enzymes, Kits & Reagents Market, by Application– Revenue and Forecast to 2028 (USD Million)

Table 8. France: Molecular Biology Enzymes, Kits & Reagents Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 9. United Kingdom: Molecular Biology Enzymes, Kits & Reagents Market, by Product– Revenue and Forecast to 2028 (USD Million)

Table 10. United Kingdom: Molecular Biology Enzymes, Kits & Reagents Market, by Enzymes– Revenue and Forecast to 2028 (USD Million)

Table 11. United Kingdom: Molecular Biology Enzymes, Kits & Reagents Market, by Application– Revenue and Forecast to 2028 (USD Million)

Table 12. United Kingdom: Molecular Biology Enzymes, Kits & Reagents Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 13. Italy: Molecular Biology Enzymes, Kits & Reagents Market, by Product– Revenue and Forecast to 2028 (USD Million)

Table 14. Italy: Molecular Biology Enzymes, Kits & Reagents Market, by Enzymes– Revenue and Forecast to 2028 (USD Million)

Table 15. Italy: Molecular Biology Enzymes, Kits & Reagents Market, by Application– Revenue and Forecast to 2028 (USD Million)

Table 16. Italy: Molecular Biology Enzymes, Kits & Reagents Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 17. Spain: Molecular Biology Enzymes, Kits & Reagents Market, by Product– Revenue and Forecast to 2028 (USD Million)

Table 18. Spain: Molecular Biology Enzymes, Kits & Reagents Market, by Enzymes– Revenue and Forecast to 2028 (USD Million)

Table 19. Spain: Molecular Biology Enzymes, Kits & Reagents Market, by Application– Revenue and Forecast to 2028 (USD Million)

Table 20. Spain: Molecular Biology Enzymes, Kits & Reagents Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 21. Rest of Europe: Molecular Biology Enzymes, Kits & Reagents Market, by Product– Revenue and Forecast to 2028 (USD Million)

Table 22. Rest of Europe: Molecular Biology Enzymes, Kits & Reagents Market, by Enzymes– Revenue and Forecast to 2028 (USD Million)

Table 23. Rest of Europe: Molecular Biology Enzymes, Kits & Reagents Market, by Application– Revenue and Forecast to 2028 (USD Million)

Table 24. Rest of Europe: Molecular Biology Enzymes, Kits & Reagents Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 25. Recent Inorganic Developments In The Molecular Biology Enzymes, Kits & Reagents Market

Table 26. Glossary of Terms, Molecular Biology Enzymes, Kits & Reagents Market

LIST OF FIGURES

Figure 1. Europe Molecular Biology Enzymes, Kits & Reagents Market Segmentation

Figure 2. Europe Molecular Biology Enzymes, Kits & Reagents Market Segmentation, By Country

Figure 3. Europe Molecular Biology Enzymes, Kits & Reagents Market Overview

Figure 4. Kits and Reagents Segment Held Largest Share of Europe Molecular Biology Enzymes, Kits & Reagents Market

Figure 5. UK to Show Remarkable Growth During Forecast Period

Figure 6. Europe PEST Analysis

Figure 7. Europe Molecular Biology Enzymes, Kits, and Reagents Market Impact Analysis of Driver and Restraints

Figure 8. Europe Molecular Biology Enzymes, Kits & Reagents Market – Revenue Forecast and Analysis – 2019- 2028

Figure 9. Europe Molecular Biology Enzymes, Kits & Reagents Market Revenue Share, by Product (2020 and 2028)

Figure 10. Europe Enzymes: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)

Figure 11. Europe Polymerases: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12. Europe Ligase: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13. Europe Reverse Transcriptases: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14. Europe Phosphatases: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15. Europe Proteases and Proteinases: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16. Europe Restriction Endonuclease: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17. Europe Others: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18. Europe Kits and Reagents: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19. Europe Molecular Biology Enzymes, Kits & Reagents Market Revenue Share, by Application (2020 and 2028)

Figure 20. Europe Polymerase Chain Reaction: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21. Europe Sequencing: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22. Europe Synthetic Biology: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)

Figure 23. Europe Epigenetics: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)

Figure 24. Europe Others: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25. Europe Molecular Biology Enzymes, Kits & Reagents Market, by End User, 2020 and 2028 (%)

Figure 26. Europe Biotechnological and Pharmaceutical Companies: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27. Europe Hospitals and Diagnostic Centers: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)

Figure 28. Europe Academic and Research Institute: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)

Figure 29. Europe: Molecular Biology Enzymes, Kits & Reagents Market, by Key Country – Revenue (2020) (USD Million)

Figure 30. Europe: Molecular Biology Enzymes, Kits & Reagents Market, by Country, 2020 & 2028 (%)

Figure 31. Germany: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (USD Million)

Figure 32. France: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (USD Million)

Figure 33. United Kingdom: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (USD Million)

Figure 34. Italy: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (USD Million)

Figure 35. Spain: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (USD Million)

Figure 36. Rest of Europe: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (USD Million)

Figure 37. Impact of COVID-19 Pandemic in European Country Markets

Figure 38. Growth Strategies In The Molecular Biology Enzymes, Kits & Reagents Devices Market, 2018-2021

  1. Agilent Technologies, Inc.
  2. F. HOFFMANN-LA ROCHE LTD
  3. Illumina, Inc.
  4. Merck KGAA
  5. MERIDIAN BIOSCIENCE, INC
  6. Promega Corporation
  7. Qiagen
  8. Rockland Immunochemicals Inc 
  9. THERMO FISHER SCIENTIFIC INC
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe molecular biology enzymes, kits, and reagents market
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the Europe molecular biology enzymes, kits, and reagents market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the molecular biology enzymes, kits, and reagents market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution
TIPRE00025774
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.